Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.38 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8237740 | 0.90 | GSK3B (0.47) | GSK3BCHRNA7NR2E3METPIK3C3 | |
| SCHEMBL4149995 | 0.90 | GSK3B (0.47) | GSK3BCHRNA7PIK3C3PARP1 | |
| SCHEMBL4148346 | 0.84 | RAB9A (0.53) | GSK3BNR2E3 | |
| SCHEMBL4148260 | 0.84 | GSK3B (0.55) | GSK3B | |
| SCHEMBL4162671 | 0.82 | GSK3B (0.47) | GSK3B | |
| SCHEMBL8237367 | 0.82 | GSK3B (0.49) | GSK3BCHRNA7PARP1 | |
| SCHEMBL4152183 | 0.81 | GSK3B (0.56) | GSK3BMET | |
| SCHEMBL4152806 | 0.80 | GSK3B (0.57) | GSK3BMET | |
| SCHEMBL4152144 | 0.80 | GSK3B (0.60) | GSK3BMET | |
| SCHEMBL13778103 | 0.80 | GSK3B (0.48) | GSK3BPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090170847-A1 | Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same | YUYU PHARMA, INC. (KR) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170847-A1 | Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same | GSK3B, GSK3A, MAP3K3 | GSK3B 1/4885CHRNA7 1753/4885NR2E3 4077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.